5IBT

UCA Fab (unbound) from 6515 Lineage


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.4 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.205 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.

Raymond, D.D.Stewart, S.M.Lee, J.Ferdman, J.Bajic, G.Do, K.T.Ernandes, M.J.Suphaphiphat, P.Settembre, E.C.Dormitzer, P.R.Del Giudice, G.Finco, O.Kang, T.H.Ippolito, G.C.Georgiou, G.Kepler, T.B.Haynes, B.F.Moody, M.A.Liao, H.X.Schmidt, A.G.Harrison, S.C.

(2016) Nat. Med. 22: 1465-1469

  • DOI: 10.1038/nm.4223
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • For broad protection against infection by viruses such as influenza or HIV, vaccines should elicit antibodies that bind conserved viral epitopes, such as the receptor-binding site (RBS). RBS-directed antibodies have been described for both HIV and in ...

    For broad protection against infection by viruses such as influenza or HIV, vaccines should elicit antibodies that bind conserved viral epitopes, such as the receptor-binding site (RBS). RBS-directed antibodies have been described for both HIV and influenza virus, and the design of immunogens to elicit them is a goal of vaccine research in both fields. Residues in the RBS of influenza virus hemagglutinin (HA) determine a preference for the avian or human receptor, α-2,3-linked sialic acid and α-2,6-linked sialic acid, respectively. Transmission of an avian-origin virus between humans generally requires one or more mutations in the sequences encoding the influenza virus RBS to change the preferred receptor from avian to human, but passage of a human-derived vaccine candidate in chicken eggs can select for reversion to avian receptor preference. For example, the X-181 strain of the 2009 new pandemic H1N1 influenza virus, derived from the A/California/07/2009 isolate and used in essentially all vaccines since 2009, has arginine at position 226, a residue known to confer preference for an α-2,3 linkage in H1 subtype viruses; the wild-type A/California/07/2009 isolate, like most circulating human H1N1 viruses, has glutamine at position 226. We describe, from three different individuals, RBS-directed antibodies that recognize the avian-adapted H1 strain in current influenza vaccines but not the circulating new pandemic 2009 virus; Arg226 in the vaccine-strain RBS accounts for the restriction. The polyclonal sera of the three donors also reflect this preference. Therefore, when vaccines produced from strains that are never passaged in avian cells become widely available, they may prove more capable of eliciting RBS-directed, broadly neutralizing antibodies than those produced from egg-adapted viruses, extending the established benefits of current seasonal influenza immunizations.


    Organizational Affiliation

    Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, USA.,Department of Chemical Engineering, University of Texas at Austin, Austin, Texas, USA.,Duke Human Vaccine Institute, Duke University Medical School, Durham, North Carolina, USA.,Department of Medicine, Duke University Medical School, Durham, North Carolina, USA.,Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School.,Howard Hughes Medical Institute, Boston, Massachusetts, USA.,Graduate Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.,Center of Systems and Synthetic Biology, University of Texas at Austin, Austin, Texas, USA.,Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.,Novartis Vaccines and Diagnostics, Siena, Italy.,Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.,Department of Pediatrics, Duke University Medical School, Durham, North Carolina, USA.,Seqirus, 45 Sidney St., Cambridge, Massachusetts, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
UCA Heavy Chain
H
230N/AMutation(s): 0 
Protein Feature View is not available: No corresponding UniProt sequence found.
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
UCA Light Chain
L
215N/AMutation(s): 0 
Protein Feature View is not available: No corresponding UniProt sequence found.
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
GOL
Query on GOL

Download SDF File 
Download CCD File 
H
GLYCEROL
GLYCERIN; PROPANE-1,2,3-TRIOL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.4 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.205 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 51.840α = 90.00
b = 63.390β = 90.00
c = 146.420γ = 90.00
Software Package:
Software NamePurpose
BUSTERrefinement
PHASERphasing
PDB_EXTRACTdata extraction
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of HealthUnited States--

Revision History 

  • Version 1.0: 2016-11-09
    Type: Initial release
  • Version 1.1: 2016-11-23
    Type: Database references
  • Version 1.2: 2016-12-14
    Type: Database references